Home A Beautiful Biotech Summer?
 

Keywords :   


A Beautiful Biotech Summer?

2015-05-22 22:22:48| Biotech - Topix.net

We think the tone in the group has turned back to a bullish outlook, though the ASCO meeting can create shorter-term volatility. With the innovation wave in SMid cap picking up momentum and with an event-rich summer for large caps, we remain positive on the biotech group overall While we see scenarios for upside value across multiple companies we highlight Biogen and Alexion as having particularly favorable risk / reward profiles based on very defensible core businesses and very good pipeline / launch upside, while we do not view the potential upside for Celgene , Vertex or Amgen as compelling at this time.

Tags: beautiful summer biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 7
05.11Tropical Storm Rafael Public Advisory Number 7
More »